Clinical Trial Update: Evaluation of the Protection Activity of Microfine Titanium Dioxide (Ti02), Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With Idiopathic Solar Urticaria (SU) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating protection activity of titanium dioxide and related compounds in patients with idiopathic solar urticaria; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Solar Urticaria

Drugs mentioned

• Bisoctrizole (bis-controzole)
• Microfine Titanium Dioxide (titanium dioxide microfine)
• Pigmentary Ti02 (titanium dioxide pigment)

Snippet

Sponsor: Orfagen | Conditions: Idiopathic Solar Urticaria | Phase 2 | Status: COMPLETED | Results posted: 2014-03-31